logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12545643 B1

PDFFull Text
Date of Patent:
Feb. 10, 2026

Filed:

Mar. 09, 2021

3,5-diaminobenzoic acid compound, and pin1 inhibitor and therapeutic agent for inflammatory diseases using same

Applicant:

Amenis Bioscience, Inc., Seoul, KR;

Inventors:

Tomoichiro Asano, Higashihiroshima, JP;

Yusuke Nakatsu, Higashihiroshima, JP;

Hisanaka Ito, Hachioji, JP;

Takayoshi Okabe, Tokyo, JP;

Assignee:

Amenis Bioscience, Inc, Seoul, KR;

Attorney:

Medler Ferro Woodhouse & Mills PLLC

Primary Examiner:

Brian J Davis

Int. Cl.
CPC ...
C07D 209/86 (2006.01); A61P 1/16 (2006.01); A61P 3/04 (2006.01); A61P 29/00 (2006.01); A61P 31/14 (2006.01); C07C 237/48 (2006.01); C07C 275/42 (2006.01); C07D 215/48 (2006.01); C07D 319/16 (2006.01); C07D 319/20 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 405/12 (2006.01);
U.S. Cl.
CPC ...
C07D 209/86 (2013.01); A61P 1/16 (2018.01); A61P 3/04 (2018.01); A61P 29/00 (2018.01); A61P 31/14 (2018.01); C07C 237/48 (2013.01); C07C 275/42 (2013.01); C07D 215/48 (2013.01); C07D 319/16 (2013.01); C07D 319/20 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07C 2601/16 (2017.05); C07C 2602/10 (2017.05);
Abstract

The present invention provides: a compound represented by the following Formula (I) or a salt thereof, as well as a Pin1 inhibitor, a pharmaceutical composition, a therapeutic or prophylactic agent for inflammatory diseases, a therapeutic or prophylactic agent for fatty liver diseases, a therapeutic or prophylactic agent for obesity, and a therapeutic or prophylactic agent for COVID-19 that utilize the aforementioned compounds or the salts thereof to develop a group of novel compounds with an inhibitory activity against the function of Pin1 so as to use them as candidate compounds for medicaments.

Find Patent Forward Citations

Asano, Tomoichiro. (2026). 3,5-diaminobenzoic acid compound, and pin1 inhibitor and therapeutic agent for inflammatory diseases using same (U.S. Patent No. 12545643). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12545643

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…